Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Avenue Therapeutics | ATXI | 17. avr 2025 | 0.85 | 0.00 |
AvePoint A | AVPT | 17. avr 2025 | 14.43 | -1.50 |
Avery Dennison | AVY | 17. avr 2025 | 170.85 | +1.61 |
Aviat Networks | AVNW | 17. avr 2025 | 17.22 | +1.50 |
Avid Bioservices | CDMO | 17. avr 2025 | 12.49 | 0.00 |
Avidity Biosciences | RNA | 17. avr 2025 | 26.66 | +3.49 |
AvidXchange | AVDX | 17. avr 2025 | 7.60 | -1.94 |
Avient | AVNT | 17. avr 2025 | 31.20 | +1.27 |
Avino Silver & Gold Mines | ASM | 17. avr 2025 | 2.01 | -1.47 |
Avis Budget Group | CAR | 17. avr 2025 | 84.59 | +16.37 |
Avista | AVA | 17. avr 2025 | 41.84 | +0.58 |
AVITA Medical ADR | RCEL | 17. avr 2025 | 9.21 | +2.11 |
Avnet | AVT | 17. avr 2025 | 47.20 | +1.48 |
Aware | AWRE | 17. avr 2025 | 1.53 | +5.86 |
Axalta Coating Systems | AXTA | 17. avr 2025 | 31.23 | +0.35 |
Axcelis Technologies | ACLS | 17. avr 2025 | 44.78 | +0.36 |
AXIL Brands | AXIL | 17. avr 2025 | 6.08 | -0.28 |
Axis Capital | AXS | 17. avr 2025 | 94.59 | -0.38 |
Axis Capital E Pref | AXS-E | 17. avr 2025 | 20.17 | -0.20 |
Axogen | AXGN | 17. avr 2025 | 15.57 | -0.06 |
Axon Enterprise | AXON | 17. avr 2025 | 559.53 | -2.15 |
Axos Financial | AX | 17. avr 2025 | 60.21 | +1.95 |
Axsome Therapeutics | AXSM | 17. avr 2025 | 104.46 | -0.01 |
AXT | AXTI | 17. avr 2025 | 1.19 | +1.71 |
AYRO | AYRO | 17. avr 2025 | 0.51 | -0.97 |
Aytu BioPharma | AYTU | 17. avr 2025 | 1.01 | -0.97 |
Azenta | AZTA | 17. avr 2025 | 25.25 | -0.98 |
Azitra | AZTR | 17. avr 2025 | 0.28 | -10.38 |
Azul ADR | AZUL | 17. avr 2025 | 1.57 | +1.95 |
AZZ | AZZ | 17. avr 2025 | 81.00 | -1.23 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.